NDC 0409-9633

Verapamil Hydrochloride

Verapamil Hydrochloride

Verapamil Hydrochloride is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Verapamil Hydrochloride.

Product ID0409-9633_1975dcaa-94b4-4af2-b95d-41463e1db00c
NDC0409-9633
Product TypeHuman Prescription Drug
Proprietary NameVerapamil Hydrochloride
Generic NameVerapamil Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2005-12-02
Marketing CategoryANDA / ANDA
Application NumberANDA075136
Labeler NameHospira, Inc.
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength3 mg/mL
Pharm ClassesCalcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0409-9633-05

10 CARTON in 1 CONTAINER (0409-9633-05) > 1 SYRINGE, PLASTIC in 1 CARTON > 4 mL in 1 SYRINGE, PLASTIC (0409-9633-65)
Marketing Start Date2005-12-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-9633-65 [00409963365]

Verapamil Hydrochloride INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA075136
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-05-11

NDC 0409-9633-05 [00409963305]

Verapamil Hydrochloride INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA075136
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-12-02

Drug Details

Active Ingredients

IngredientStrength
VERAPAMIL HYDROCHLORIDE2.5 mg/mL

OpenFDA Data

SPL SET ID:1c993365-1b62-4524-e781-d307f28f63bc
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1665057
  • 898316
  • 1665061
  • Pharmacological Class

    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]